MoonLake Immunotherapeutics, Applied Digital And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Portfolio Pulse from Lisa Levin
Several stocks recorded losses in today's pre-market trading session, including Adicet Bio, Applied Digital, Cool Company, Chijet Motor, Shengfeng Development, MoonLake Immunotherapeutics, and American Lithium. Factors include trial data, downgrades, revenue and loss forecasts, and public offerings.
June 27, 2023 | 10:25 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Adicet Bio shares dipped 14.2% after reporting ADI-001 Phase 1 trial data and a downgrade from JMP Securities.
Adicet Bio's stock price is likely to go down in the short term due to the negative trial data and the downgrade from JMP Securities, which may cause investors to lose confidence in the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
American Lithium shares declined 3% after posting a Q4 loss of 5 cents per share.
American Lithium's stock price is likely to go down in the short term due to the company's Q4 loss, which may cause investors to question the company's profitability.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Applied Digital shares dropped 4.8% as the company forecasts Q4 revenue of $22 million and a net loss of $6.8 million.
Applied Digital's stock price is likely to go down in the short term due to the company's negative financial forecast, which may cause investors to question the company's profitability.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Chijet Motor shares declined 4.1% in pre-market trading.
Chijet Motor's stock price is likely to go down in the short term, but the article does not provide any specific reasons for the decline.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Cool Company shares fell 4.5% in pre-market trading.
Cool Company's stock price is likely to go down in the short term, but the article does not provide any specific reasons for the decline.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
MoonLake Immunotherapeutics shares fell 3.2% after announcing a $250 million proposed underwritten public offering.
MoonLake Immunotherapeutics' stock price is likely to go down in the short term due to the announcement of a proposed underwritten public offering, which may dilute existing shareholders' ownership.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Shengfeng Development shares dropped 3.4% in pre-market trading after climbing 33% on Monday.
Shengfeng Development's stock price is likely to go down in the short term due to profit-taking after the significant climb on Monday.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100